Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.16 USD | -0.36% | -2.37% | -8.52% |
31/05 | Piper Sandler Starts Arcellx With Overweight Rating, $70 Price Target | MT |
15/05 | Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARCELLX, INC. | Other Biotechnology & Medical Research | -1.11% | -2.37% | -8.52% | +20.94% | - | 274.68Cr |
- Stock Market
- Equities
- ACLX Stock
- Charts Arcellx, Inc.
- Relative Strength Chart